4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000184
Chairperson & CEO sold 7,886 shares at an average $572.69 ($4,516,253)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
25 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-09 | Sale : show line 2 in the form 10b5-1 | −80 | $556.52 | $44,522 | 333,863 | I |
| 2026-11-09 | Sale : show line 3 in the form 10b5-1 | −161 | $558.07 | $89,849 | 333,702 | I |
| 2026-11-09 | Sale : show line 4 in the form 10b5-1 | −168 | $558.70 | $93,862 | 333,534 | I |
| 2026-11-09 | Sale : show line 5 in the form 10b5-1 | −71 | $559.80 | $39,746 | 333,463 | I |
| 2026-11-09 | Sale : show line 6 in the form 10b5-1 | −517 | $561.15 | $290,114 | 332,946 | I |
| 2026-11-09 | Sale : show line 7 in the form 10b5-1 | −512 | $562.35 | $287,923 | 332,434 | I |
| 2026-11-09 | Sale : show line 8 in the form 10b5-1 | −291 | $563.49 | $163,976 | 332,143 | I |
| Open-market sales · 7,886 sh · avg $572.69 · $4,516,253 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 26 in the form 10b5-1 Stock Option | −9,500 | 62,410 | I |
Loading xslF345X06/primarydocument.xml…